AKESF
Price
$13.59
Change
+$0.39 (+2.95%)
Updated
Apr 25 closing price
Capitalization
11.44B
NUVL
Price
$73.48
Change
-$0.50 (-0.68%)
Updated
Apr 25 closing price
Capitalization
5.26B
10 days until earnings call
Ad is loading...

AKESF vs NUVL

Header iconAKESF vs NUVL Comparison
Open Charts AKESF vs NUVLBanner chart's image
AKESO
Price$13.59
Change+$0.39 (+2.95%)
Volume$82.83K
Capitalization11.44B
Nuvalent
Price$73.48
Change-$0.50 (-0.68%)
Volume$199.1K
Capitalization5.26B
AKESF vs NUVL Comparison Chart
Loading...
NUVL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AKESF vs. NUVL commentary
Apr 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AKESF is a Hold and NUVL is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 28, 2025
Stock price -- (AKESF: $13.59 vs. NUVL: $73.48)
Brand notoriety: AKESF and NUVL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AKESF: 604% vs. NUVL: 33%
Market capitalization -- AKESF: $11.44B vs. NUVL: $5.26B
AKESF [@Biotechnology] is valued at $11.44B. NUVL’s [@Biotechnology] market capitalization is $5.26B. The market cap for tickers in the [@Biotechnology] industry ranges from $272.78B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AKESF’s FA Score shows that 1 FA rating(s) are green whileNUVL’s FA Score has 0 green FA rating(s).

  • AKESF’s FA Score: 1 green, 4 red.
  • NUVL’s FA Score: 0 green, 5 red.
According to our system of comparison, AKESF is a better buy in the long-term than NUVL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NUVL’s TA Score shows that 6 TA indicator(s) are bullish.

  • NUVL’s TA Score: 6 bullish, 3 bearish.

Price Growth

AKESF (@Biotechnology) experienced а +26.83% price change this week, while NUVL (@Biotechnology) price change was +2.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.19%. For the same industry, the average monthly price growth was -3.08%, and the average quarterly price growth was -10.41%.

Reported Earning Dates

NUVL is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+8.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AKESF($11.4B) has a higher market cap than NUVL($5.26B). AKESF YTD gains are higher at: 94.143 vs. NUVL (-6.132).
AKESFNUVLAKESF / NUVL
Capitalization11.4B5.26B217%
EBITDAN/A-280.37M-
Gain YTD94.143-6.132-1,535%
P/E Ratio25.37N/A-
RevenueN/A0-
Total CashN/A1.12B-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
NUVL
RSI
ODDS (%)
Bullish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
86%
Momentum
ODDS (%)
Bullish Trend 4 days ago
75%
MACD
ODDS (%)
Bullish Trend 4 days ago
73%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
83%
Advances
ODDS (%)
Bullish Trend 5 days ago
81%
Declines
ODDS (%)
Bearish Trend 21 days ago
79%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
81%
Aroon
ODDS (%)
Bearish Trend 7 days ago
87%
View a ticker or compare two or three
Ad is loading...
NUVL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
EQL40.780.11
+0.27%
ALPS Equal Sector Weight ETF
BSMT22.470.03
+0.13%
Invesco BulletShares 2029 Muncpl Bd ETF
CHPS26.77N/A
N/A
Xtrackers Semiconductor Select Eq ETF
ITB91.26-0.89
-0.97%
iShares US Home Construction ETF
GOEX40.72-0.63
-1.54%
Global X Gold Explorers ETF

AKESF and

Correlation & Price change

A.I.dvisor indicates that over the last year, AKESF has been loosely correlated with INBX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if AKESF jumps, then INBX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AKESF
1D Price
Change %
AKESF100%
+2.95%
INBX - AKESF
45%
Loosely correlated
+2.34%
SMMT - AKESF
27%
Poorly correlated
-36.06%
NUVL - AKESF
25%
Poorly correlated
-0.68%
BNTX - AKESF
23%
Poorly correlated
-15.36%
CPMV - AKESF
22%
Poorly correlated
N/A
More

NUVL and

Correlation & Price change

A.I.dvisor indicates that over the last year, NUVL has been loosely correlated with ABCZF. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if NUVL jumps, then ABCZF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NUVL
1D Price
Change %
NUVL100%
-0.68%
ABCZF - NUVL
51%
Loosely correlated
N/A
ROIV - NUVL
47%
Loosely correlated
+0.09%
KYMR - NUVL
47%
Loosely correlated
-0.89%
RVMD - NUVL
44%
Loosely correlated
+0.49%
CRNX - NUVL
44%
Loosely correlated
-2.99%
More